Publications By Our Physicians
ALS
A
novel, efficient, randomized selection trial comparing combinations of
drug therapy for ALS.
Whole-genome
analysis of sporadic amyotrophic lateral sclerosis.
Efficacy
of minocycline in patients with amyotrophic lateral sclerosis: a phase
III randomised trial.
Brachial
amyotrophic diplegia: a slowly progressive motor neuron disorder.
CIDP
Chronic
Inflammatory Demyelinating Polyneuropathy
Clinical
spectrum of chronic acquired demyelinating polyneuropathies.
Distal
acquired demyelinating symmetric neuropathy.
IgM
antibody-related polyneuropathies: B-cell depletion chemotherapy using
Rituximab.
Treatment
of IgM antibody associated polyneuropathies using rituximab.
Dermatomyositis
Rituximab
in the treatment of dermatomyositis: an open-label pilot study.
History
of dermatomyositis
Guillain Barre
Guillain-Barre
syndrome and chronic inflammatory demyelinating polyneuropathy.
Inclusion body myositis
Pilot
trial of etanercept in the treatment of inclusion-body myositis.
Muscular dystrophy
Clinical and genetic aspects of distal myopathies.
Multiple Sclerosis
Avonex Combination Trial in relapsing--remitting MS:
rationale, design and baseline data.
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Myasthenia gravis
Management
of myasthenia gravis.
Peripheral Neuropathy
Peripheral
neuropathy in an outpatient cohort of patients with Sjögren's
syndrome.
Peripheral
neuropathies in Waldenström's macroglobulinaemia.
Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel
recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Chronic
acquired demyelinating polyneuropathies.
IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using
Rituximab.
Treatment of IgM antibody associated polyneuropathies using rituximab.
Peripheral Neuropathy Due to Cobalamin Deficiency
Challenges in the identification of cobalamin-deficiency polyneuropathy.
Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics.
Polymyositis
Inflammatory
myopathy with cytochrome oxidase negative muscle fibers: methotrexate treatment.
Other
Muscle channelopathies.
|
